Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery

NCT02031536 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

NETWORK

Sponsor class

Stopped Slow accrual

Conditions

Gastrinoma
Glucagonoma
Insulinoma
Liver Metastases
Pancreatic Polypeptide Tumor
Recurrent Islet Cell Carcinoma
Somatostatinoma

Interventions

DRUG: everolimus
OTHER: placebo

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]